These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37194127)

  • 1. Uptake of genetic testing among patients seeking cancer genetic counseling in Taiwan.
    Fang SY; Hsieh LL; Hung CF; Wang YA
    J Genet Couns; 2024 Apr; 33(2):322-328. PubMed ID: 37194127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitude towards hereditary cancer risk management among women with cancer in Taiwan.
    Fang SY; Hsieh LL; Hung CF; Hung FH; Peng HP; Yang AS; Wang YA
    Support Care Cancer; 2022 Apr; 30(4):3625-3632. PubMed ID: 35028717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single-country, multi-center, patient-reported outcome study.
    Kuo WL; Lin PH; Peng MT; Chu CH; Cho CW
    J Genet Couns; 2023 Aug; 32(4):788-797. PubMed ID: 36872635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.
    Glanz K; Grove J; Lerman C; Gotay C; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):329-36. PubMed ID: 10207637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations].
    Jonsdottir T; Valdimarsdottir H; Tryggvadottir L; Lund SH; Thordardottir M; Magnusson MK; Valdimarsdottir U
    Laeknabladid; 2018 Juni; 104(6):289-296. PubMed ID: 29863481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
    Walker EJ; Carnevale J; Pedley C; Blanco A; Chan S; Collisson EA; Tempero MA; Ko AH
    Fam Cancer; 2019 Apr; 18(2):241-251. PubMed ID: 30267352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: a comparison of participants and nonparticipants in genetic counseling.
    Keller M; Jost R; Kadmon M; Wüllenweber HP; Haunstetter CM; Willeke F; Jung C; Gebert J; Sutter C; Herfarth C; Büchler MW
    Dis Colon Rectum; 2004 Feb; 47(2):153-62. PubMed ID: 15043284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
    Armstrong K; Micco E; Carney A; Stopfer J; Putt M
    JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of genetic testing uptake in newly diagnosed breast cancer patients.
    Ladd MK; Peshkin BN; Isaacs C; Hooker G; Willey S; Valdimarsdottir H; DeMarco T; O'Neill S; Binion S; Schwartz MD;
    J Surg Oncol; 2020 Aug; 122(2):134-143. PubMed ID: 32346886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating genetic counseling and testing in the pediatric oncology setting: Parental attitudes and influencing factors.
    Desrosiers LR; Quinn E; Cramer S; Dobek W
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27907. PubMed ID: 31294517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: Results from the 2015 National Health Interview Survey.
    Turbitt E; Roberts MC; Taber JM; Waters EA; McNeel TS; Biesecker BB; Klein WMP
    Prev Med; 2019 Jun; 123():12-19. PubMed ID: 30817954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer.
    Hadley DW; Jenkins J; Dimond E; Nakahara K; Grogan L; Liewehr DJ; Steinberg SM; Kirsch I
    Arch Intern Med; 2003 Mar; 163(5):573-82. PubMed ID: 12622604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
    Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early adoption of BRCA1/2 testing: who and why.
    Armstrong K; Weiner J; Weber B; Asch DA
    Genet Med; 2003; 5(2):92-8. PubMed ID: 12644778
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.